Abstract
The publishers would like to apologize for the accidental online duplication of “Efficacy and tolerability of GLP-1 agonists in patients with type 2 diabetes mellitus: an Indian perspective”, by Mala Darmalingham. The final version of record has the DOI 10.1177/2042018814552657 and appears in this issue, Volume 5, issue 6, December 2014.
